John McEvoy

Professor of Preventive Cardiology

Ireland

Research Interests

Explore related searches

Professors in Ireland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

John McEvoy is a Professor of Preventive Cardiology at the National University of Ireland Galway School of Medicine. His research encompasses a wide range of topics including high blood pressure management, cardiac rehabilitation, and patient perspectives on cardiovascular disease prevention. He has contributed significantly to the literature on evidence-based clinical practices, psychological factors in cardiovascular outcomes, and the latest guidelines from the European Society of Cardiology. Professor McEvoy's work is highly relevant to improving clinical care and patient outcomes in cardiovascular health.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (34)

Kornelia Kotseva

National University of Ireland Galway

IRELAND

John McEvoy

Research Interests

Explore related searches

Contact this professor

About

Articles (29)

Cardiac rehabilitation in patients with coronary heart disease - provision, attendance, and outcomes: results from the INTERASPIRE survey from fourteen countries across six WHO regions

Patient perceptions on lipoprotein(a) testing and treatment for secondary prevention of cardiovascular disease: results from the INTERASPIRE study in seven countries across five World Health Organization regions

2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations II: diagnostic tests and prediction models

What Is New and Different in the 2024 European Society of Cardiology Guidelines for the Management of Elevated Blood Pressure and Hypertension?

Implementing the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Leveraging Evidence to Push the Boundaries of Clinical Care

Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients

Observational data supporting ambulatory-monitored blood pressure treatment targets in 2024 ESC Guidelines

Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction

Insights from Norway on implementing the 2024 European Society of Cardiology Guidelines for elevated blood pressure and hypertension

2024 ESC Guidelines for the management of elevated blood pressure and hypertension.

Semaglutide and blood pressure: an individual patient data meta-analysis

Outcomes After Aspirin Discontinuation Among Baseline Users in Contemporary Primary Prevention Aspirin Trials: A Meta-Analysis

Variation in secondary prevention of coronary heart disease: the INTERASPIRE study

From Treating Hypertension to Lowering Cardiovascular Disease Risk

Selected highlights in the updated treatment of hypertension

Determinants of High‐Sensitivity Cardiac Troponin T and I in US Children and Adolescents

PREVENT Equations: A New Era in Cardiovascular Disease Risk Assessment

Baseline Diastolic BP and BP-Lowering Effects on Cardiovascular Outcomes and All-Cause Mortality: A Meta Analysis

Behaviour change techniques and intervention characteristics in digital cardiac rehabilitation: a systematic review and meta-analysis of randomised controlled trials

The 2017 American College of Cardiology/American Heart Association Hypertension Guideline and Blood Pressure in Older Adults

NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study

Associations of Cardiac Biomarkers With Peripheral Artery Disease and Peripheral Neuropathy in US Adults Without Prevalent Cardiovascular Disease

Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in a Population-Based Sample of US Children and Adolescents

Instrumental variables, in silico trial simulation, and cutting-edge analysis in cardiology: with great power comes great responsibility

High-sensitivity troponins and mortality in the general population

Subclinical Cardiovascular Disease in US Adults With and Without Diabetes

Letter by Gibson and McEvoy Regarding Article, “Influence of Age on the Diagnosis of Myocardial Infarction”

The Apples and Oranges of Blood Pressure Variability

Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension—Con Side of the Argument

Collaborators (34)

Kornelia Kotseva

Justin B. Echouffo‐Tcheugui

Glenn M Chertow

John McNeil

Kathryn Foti

Caitlin Hicks

Luís Bronze

Molly Byrne

Victor Aboyans

Michelle Canavan

Josef Coresh

Adonis Samuel Chibuike James

David Thompson

Stephen Juraschek

Christian Heiss

RICCARDO ASTEGGIANO

Rhian M. Touyz

Lina Zgaga

Tammy Brady

Sadiya Khan

Piotr Jankowski

Henner Hanssen

James Curneen

Darren McGuire

Rosa Maria Bruno

Jaimini Cegla

Kazem Rahimi

Natalie Daya

Kausik Ray

Peter Jüni

Xavier Rossello

Erin Michos

Carel Le Roux

Borislava Mihaylova

Make your next move.